Urinary inflammatory mediators and inhalation of hypertonic saline in children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 1, 2005, Pages 60-64

  Mai, Xiao Mei ^a   Bottcher M F ^a   Bruhammar, M ^a   Nilsson, L ^a   Zetterstrom O ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Bronchial hyperreactivity; Hypertonic saline (HS); Inflammatory mediators; Urine

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; EOSINOPHIL PROTEIN X; HISTAMINE; LEUKOTRIENE E4; SODIUM CHLORIDE;

AIRWAY OBSTRUCTION; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; INHALATION TEST; MEDIATOR; PRIORITY JOURNAL; PROVOCATION; PROVOCATION TEST; RADIOIMMUNOASSAY; SCHOOL CHILD; URINALYSIS; URINARY EXCRETION;

ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CASE-CONTROL STUDIES; CHILD; FEMALE; HISTAMINE; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENE E4; MALE; SALINE SOLUTION, HYPERTONIC;

EID: 12444273640     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00623.x     Document Type: Article

References (20)

1. Riedler J, Gamper A, Eder W, Oberfeld G. Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children. Eur Respir J 1998;11:355-360.
2. Riedler J, Reade T, Dalton M, Holst D, Robertson C. Hypertonic saline challenge in an epidemiologic survey of asthma in children. Am J Respir Crit Care Med 1994;150:1632-1639.
3. Mai X-M, Nilsson L, Kjellman N-IM, Björkstén B. Hypertonic saline challenge tests in the diagnosis of bronchial hyperresponsiveness and asthma in children. Pediatr Allergy Immunol 2002;13:361-367.
4. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984;130:86-91.
5. Eggleston PA. Kagey-Sobotka A, Lichtenstein LM. A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis 1987;135:1043-1048.
6. Eggleston PA, Kagey-Sobotka A, Proud D, Adkinson NF Jr, Lichtenstein LM. Disassociation of the release of histamine and arachidonic acid meabolites from osmotically activated basophils and human lung mast cells. Am Rev Respir Dis 1990;141:960-964.
7. Gravelyn TR, Pan PM, Eschenbacher WL. Mediator release in an isolated airway segment in subjects with asthma. Am Rev Respir Dis 1988;137:641-646.
8. O'Hickey SP, Belcher NG, Rees PJ, Lee TH. Role of histamine release in hypertonic saline induced bronchoconstriction. Thorax 1989;44:650-653.
9. Silber G, Proud D, Warner J, Naclerio R, Kagey-Sobotka A, Lichtenstein L et al. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis 1988;137:606-612.
10. Mai X-M, Gäddlin PO, Nilsson L, Finnström O, Björkstén B, Jenmalm MC et al. Asthma, lung function and allergy in 12-year-old children with very low birth weight: a prospective study. Pediatr Allergy Immunol 2003;14:184-192.
11. Devillier P, Baccard N, Advenier C. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. Pharmacol Res 1999;40:3-13.
12. Kumlin M. Measurements of leukotrienes in the urine: strategies and applications. Allergy 1997;52:124-135.
13. 2 metabolites as markers of mast cell activation in asthma. Acta Physiol Scand Suppl 1999;644:1-74.
14. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003;22:491-496.
15. Just J, Fournier L, Momas I, Zambetti C, Sahraoui F, Grimfeld A. Clinical significance of bronchoalveolar eosinophils in childhood asthma. J Allergy Clin Immunol 2002;110:42-44.
16. Xu LJ, Olivenstein R, Martin JG, Powell WS. Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats. J Appl Physiol 2000;89:1852-1858.
17. Reimert CM, Minuva U, Kharazmi A, Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/ EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine. J Immunol Methods 1991;141:97-104.
18. Wolthers OD, Heuck C. Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X. Pediatr Allergy Immunol 2003;14:130-133.
19. O'Sullivan S, Roquet A, Dahlén B, Dahlén SE, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998;28:1332-1339.
20. Dahlén B, Kumlin M, Ihre E, Zetterström O, Dahlén SE. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx1005. Thorax 1997;52:342-347.